Compare LAD & QGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LAD | QGEN |
|---|---|---|
| Founded | 1946 | 1986 |
| Country | United States | Netherlands |
| Employees | N/A | N/A |
| Industry | Retail-Auto Dealers and Gas Stations | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.1B | 9.0B |
| IPO Year | 1996 | 1998 |
| Metric | LAD | QGEN |
|---|---|---|
| Price | $356.81 | $42.33 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 9 | 8 |
| Target Price | ★ $361.89 | $45.76 |
| AVG Volume (30 Days) | 167.3K | ★ 2.7M |
| Earning Date | 04-29-2026 | 05-06-2026 |
| Dividend Yield | 0.76% | ★ 7.17% |
| EPS Growth | ★ 9.01 | N/A |
| EPS | ★ 15.68 | N/A |
| Revenue | ★ $11,821,400,000.00 | N/A |
| Revenue This Year | $4.06 | $8.18 |
| Revenue Next Year | $4.18 | $5.71 |
| P/E Ratio | ★ $23.45 | $24.01 |
| Revenue Growth | ★ 17.20 | N/A |
| 52 Week Low | $239.78 | $32.53 |
| 52 Week High | $439.49 | $57.82 |
| Indicator | LAD | QGEN |
|---|---|---|
| Relative Strength Index (RSI) | 47.36 | 45.80 |
| Support Level | $356.51 | $41.14 |
| Resistance Level | $383.82 | $42.33 |
| Average True Range (ATR) | 9.99 | 1.09 |
| MACD | -2.00 | -0.26 |
| Stochastic Oscillator | 13.58 | 19.74 |
Lithia Motors is a retailer of new and used vehicles and related services. The company offers nearly 60 brands of vehicles at nearly 500 stores globally across the US, Canada, and UK. The company has expanded largely through the acquisition of dealerships in smaller regional markets but now seeks to grow in any part of the US. We expect more deals over time in the US and, at times, abroad. Annual revenue in 2025 was $37.6 billion, and we see over $50 billion possible in a few years. The US was 78.5% of 2025 revenue and the UK second at 18.4%, due to the 2024 Pendragon acquisition. In 2025, new vehicle sales were about 50% of total revenue. Lithia was founded in 1946, went public in 1996, and is the largest US auto dealer. It is based in Medford, Oregon.
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables, with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2024 sales), followed by Europe, the Middle East, and Africa (33%) and Asia-Pacific (15%).